To the Editor Carbapenems (i.e. ertapenem, imipenem, meropenem, and doripenem) are second line antimicrobials reserved to treat serious infections, including those caused by Gramnegative bacilli (GNB) producing extended-spectrum b-lactamses (ESBLs). ESBLs mediate resistance among GNB to b-lactam drugs, including third generation cephalosporins. Emergence of carbapenemases-producing GNB (mainly Acinetobacter baumanii, Pseudomonas aeruginosa, and members of the family Enterobacteriaceae) in the last decade is a serious health problem globally. Carbapenemases are members of three molecular groups of b-lactamases, Ambler class A, B (i.e. metallo b-lactamases [MBLs]), and D (i.e. oxacillinases) (1, 2) . Recently, the novel carbapenemase New Delhi MBL (NDM) was reported for the first time in Tunisia in Klebsiella pneumoniae isolated from a female patient transferred from Libya (3). However, there is little information regarding genes associated with carbapenem resistance among GNB in Libya.
Included in the study were eight GNB isolates that are resistant to at least one carbapenem (i.e. ertapenem) obtained in 2013 and 2014 from different clinical specimens from patients at the time an infection occurred. Patients were aged between 10 and 87 years (mean 037.1 years). Information about patients and the organisms isolated from them included in the study are shown in Table 1 . In this prospective investigation, clinical specimens were collected under approved ethical standards, and the study was reviewed and approved by the Academy of Graduate Studies, Tripoli, Libya.
All specimens were cultured on plates of blood agar and MacConkey agar (Oxoid Ltd., Basingstoke, Hampshire, UK) and incubated at 378C for 24Á48 h. Isolated organisms were identified to the species level and tested for their susceptibility to avariety of antimicrobial agents by the BD Phoenix Automated Microbiology System (PAMS, MSBD Biosciences, Sparks, MD, USA) as recommended by the manufacturer. PAMS provides antimicrobial susceptibility results as susceptible (S), intermediate susceptible (I), or resistant (R) and are interpreted according to Clinical and Laboratory Standards Institute criteria (4). Quality control strains used included Escherichia coli ATCC 25922, K. pneumoniae ATCC 700603, and P. aeruginosa ATCC 27853 (ATCC, LGC Standards S.r.l., Italy). Furthermore, six of the GNB isolates were tested phenotypically for the production of MBLs by the MIC Test Strip MBL (Liofilchem, Rosetodegli Abruzzi, Italy) as recommended by the manufacturer.
All eight isolates were examined for genes encoding ESBLs bla CTX-M , bla GES , bla VEB , bla PER , or bla BES and carbapenemases bla KPC , bla VIM , bla NDM , or bla OXA-48 by polymerase chain reaction (PCR) using primers and conditions described previously (5, 6 ). In addition, both A. baumanii isolates were further tested for carbapenemase genes bla OXA-23-like , bla OXA-24/40-like , bla OXA-143-like , bla OXA-51-like , and bla OXA-58-like using PCR as above.
All A. baumanii and Pseudomonas sp. isolates were resistant to the three carbapenems as well as to nearly all other antimicrobials that were used. Only colisitin showed excellent activity against the GNB isolates investigated (100% susceptible) followed by amikacin (50% susceptible). Furthermore, all organisms were multidrug resistant (MDR; resistance to three or more antimicrobial groups). Table 2 shows the antimicrobial susceptibility of the investigated GNB isolates.
Of the ESBLs genes examined, bla CTX-M was detected in one K. pneumoniae and in the Enterobacter gergoviae isolate, and bla GES in the P. aeruginosa isolate. Other ESBL genes examined were not detected in all eight GNB isolates. Of the carbapenemase genes investigated, bla NDM was detected in one K. pneumoniae, and bla OXA-48 in E. gergoviae and in another K. pneumoniae isolate. On the other hand, the carbapenemase gene bla KPC was not detected in all isolates investigated. Table 3 shows genes encoding ESBLs and carbapenemases in the GNB isolates from Tripoli, Libya.
Oxacillinases are mainly present in Acinetobacter sp. (7), and some of them are intrinsic to the organism (e.g. OXA-51) while others are acquired (e.g. OXA-23). bla OXA-23-like and bla OXA-51-like were found in both A. baumanii isolates. Recently, Mathlouthi et al. (8) reported MDR A. baumannii isolates harboring bla OXA-23-like , bla OXA-24-like , and bla OXA-48-like genes in Libya.
On the other hand, we identified OXA-48 in one K. pneumoniae as well as in the E. gergoviae isolate. Kocsis et al. (9) Table 2 . Antimicrobial susceptibility and metallo-b-lactamases of Gram-negative bacilli isolates from different clinical specimens in Tripoli, Libya
Antimicrobial agent
No.
Organism AM CN EP IP MP CX CR CT CZ CP AN PT TS CF LF CL MBLs
AK0amikacin, CN 0gentamicin, EP0ertapenem, IP0imipenem, MP 0meropenem, CX 0cefoxitin, CR 0cefuroxime, CT0ceftriaxone, CZ0ceftazidime, CP 0cefepime, AN 0aztronam, PT0pipracillin-tazobactam, TS0trimethoprim-sulfamethoxazole, CF 0ciprofloxacin, LF0levofloxacin, CL 0colisitin. S 0susceptible, I 0intermediate susceptible, R 0resistant, MTLs0metallo b-lactamases tested phenotypically, '0 positive, (0negative, ND 0not done. 
Klebsiella pneumoniae
ESBLs genes bla VEB , bla PER and bla BES and carbapenemase gene bla KPC were not detected in all eight isolates tested. Carbapenemases genes bla OXA-24/40-like , bla OXA-58-like and bla OXA-143 were not detected in both A. baumanii isolates examined. N 0negative, P 0positive, ND 0not done. Libya to neighboring and European countries (e.g. Tunisia, Denmark, and Slovenia) (3, 10Á12). However, there are no reports of bla OXA-48 -positive K. pneumonia and E. gergoviae from Libya. Both bla CTX-M and bla NDM were detected in Klebsiella pneumoniae isolated from an ear swab from a female outpatient with an ear infection. This isolate was also positive for MBLs by the phenotypic method used (Table 2 ). K. pneumoniae harboring bla NDM has not been reported from Libya in the past.
Genes coding for the ESBLs and carbapenemases tested were not detected in the E. coli isolate. However, the organism was ESBL-positive phenotypically (data not shown), which may suggest that other ESBLs not investigated in this work might be responsible for its resistance to the third generation cephalosporin.
In conclusion, to the authors' knowledge this is the first report from Libya of K. pneumoniae harboring bla NDM and bla CTX-M , K. pneumoniae harboring bla OXA-48 , and E. gergoviae harboring bla OXA-48 and bla CTX-M . Emergence of MDR GNB harboring genes coding for carbapenemases will undoubtedly limit the use of carbapenems in treating serious infectious in the country and also in the nearby countries. 
